Objective: Neurologic adverse events remain challenging complications with poor morbidity and mortality post adult allogeneic hematopoietic cell transplantation (allo-HCT) for hematologic diseases. We conducted a systematic review and meta-analysis to determine their spectrum, incidence, and impact on survival.
Methods: We searched MEDLINE, COCHRANE, EMBASE through March 2019 for all types of primary studies.